Listed

Fortress Biotech, Inc.

FBIONasdaqCIK 1429260HealthcareFiscal year ends Dec 31

Reports and events: 360 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Fortress Biotech, Inc., Reports and events
FiledFormWhat it isAccession number
2023-02-0917:03 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001558370-23-001085
2023-01-1316:13 ETSC 13D/AOwnership report, active investor, amended0001104659-23-003820
2023-01-1316:13 ETSC 13D/AOwnership report, active investor, amended0001104659-23-003819
2023-01-0616:31 ETSC 13D/AOwnership report, active investor, amended0001104659-23-001875
2022-12-1908:26 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001558370-22-018778
2022-11-1417:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-017843
2022-11-1416:16 ET10-QQuarterly reportPeriod 2022-09-300001558370-22-017763
2022-11-0416:06 ET8-K3.01 Delisting notice0001104659-22-114895
2022-10-2816:58 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-22-112516
2022-08-1116:46 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-013330
2022-08-1116:08 ET10-QQuarterly reportPeriod 2022-06-300001558370-22-013275
2022-07-2216:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001558370-22-010916
2022-07-1116:00 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001558370-22-010620
2022-06-2716:52 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001558370-22-010325
2022-05-1216:18 ET10-QQuarterly reportPeriod 2022-03-310001558370-22-008557
2022-05-1216:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-22-008553
2022-05-0217:37 ETDEF 14AProxy statementPeriod 2022-06-210001558370-22-006515
2022-03-2816:06 ET10-KAnnual reportPeriod 2021-12-310001558370-22-004487
2022-03-2808:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-038430
2021-12-0708:01 ET8-K8.01 Other events0001104659-21-147022
2021-11-1516:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-139179
2021-11-1516:06 ET10-QQuarterly reportPeriod 2021-09-300001558370-21-015968
2021-10-2708:16 ET8-K8.01 Other events0001104659-21-130293
2021-10-0616:14 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-123641
2021-09-2907:45 ET8-K8.01 Other events0001104659-21-120460
2021-09-2816:10 ET8-K4.01 Change of auditor; 8.01 Other events0001104659-21-120228
2021-09-2417:19 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001104659-21-119377
2021-08-2717:02 ET8-K8.01 Other events0001104659-21-110598
2021-08-1616:14 ET10-QQuarterly reportPeriod 2021-06-300001558370-21-011812
2021-08-1616:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-106288
2021-07-2917:01 ET8-K8.01 Other events0001104659-21-097648
2021-07-1519:17 ET8-K8.01 Other events0001104659-21-092208
2021-06-2316:15 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-21-084632
2021-06-1716:21 ET8-K8.01 Other events0001104659-21-082624
2021-05-1716:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-068111
2021-05-1716:07 ET10-QQuarterly reportPeriod 2021-03-310001558370-21-007395
2021-04-3016:02 ETDEF 14AProxy statementPeriod 2021-06-170001104659-21-058972
2021-04-1317:13 ET8-K8.01 Other events0001104659-21-049816
2021-04-0917:29 ET10-K/AAnnual report, amendedPeriod 2020-12-310001558370-21-004130
2021-04-0107:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-045172
2021-03-3116:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-044779
2021-03-3116:03 ET10-KAnnual reportPeriod 2020-12-310001558370-21-003815
2021-02-2408:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-027164
2020-12-2817:06 ETSC 13DOwnership report, active investor0001104659-20-139861
2020-11-0916:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-123101
2020-11-0916:07 ET10-QQuarterly reportPeriod 2020-09-300001558370-20-013349
2020-08-2808:10 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-099794
2020-08-2808:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity0001104659-20-099792
2020-08-1016:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-092784
2020-08-1016:02 ET10-QQuarterly reportPeriod 2020-06-300001104659-20-092702

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:27 ET. Listed shows no prices and gives no investment advice.